CLINICAL IMPLEMENTATION OF BLOOD-BASED BIOMARKERS IN NEURODEGENERATIVE DISEASES
Di Renzo Giancarlo



Crediti ECM


Destinatari


Obiettivo

Move from validation to implementation—defining what it will take for
blood-based biomarkers to reliably guide real-world clinical decisions in
neurodegenerative diseases.

Il numero di posti disponibili è esaurito


Scarica il programma



Provider
PARTNER-GRAF S.R.L.


Segreteria organizzativa
PARTNER-GRAF S.R.L.